Novel Role for Piwi/piRNA pathway in developmental robustness
Novel Role for Piwi/piRNA pathway in developmental robustness
批准号:
8787737
负责人:
VAMSI GANGARAJU
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-20 至 2016-10-31
关键词:
AffectApoptosisAubergineBindingBiochemicalBiogenesisBiological AssayBiological ModelsCell NucleusCell physiologyCellsChromatinColumn ChromatographyComplexDNA FragmentationDevelopmentDevelopmental BiologyDiseaseDrosophila genusEmbryoEmbryonic DevelopmentEnhancersEnvironmentEnvironmental PollutantsEvolutionEye DevelopmentFemale sterilityFoundationsFunctional disorderFutureGene Expression ProfileGenerationsGenesGeneticGenetic ScreeningGenotypeGerm LinesGoalsHumanHuman DevelopmentIndustrial WasteInheritedLearningLightMaintenanceMediatingMolecularMolecular ChaperonesMutagenesisOrganismPathway interactionsPeptidesPhosphorylationPlayPopulationProcessProteinsResearchResourcesRoleStem cellsStressTestingTimeToxic effectUntranslated RNAVariantWorkabstractingchromium hexavalent ioncombinatorialdosageepigenetic regulationepigenetic variationgenetic analysisgenome-widehuman diseasein vivoinsightnovelpiRNApollutantpreventprotein crosslinkresearch studyself-renewaltool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
The long term goal of our proposal is to delineate the mechanisms by which Piwi/piRNA pathway
normalizes phenotypic variation induced by severe environmental stress and inherent genotype variations.
Canalization or developmental robustness provides a framework in which organisms resist displaying
phenotypic variation in the face of combined genotype variations and severe environmental stress. Recent
research has shown that Hsp90, a molecular chaperone, plays a critical role in canalization. Despite the known
role for Hsp90, the lack of a detailed molecular mechanism underlying canalization has provoked great debate
for decades. Our lab recently validated the existence of 'canalization' and uncovered a major molecular
pathway involving Piwi, Hsp90 and Hop. Using a sensitized eye development assay, we showed that a
reduction in the maternal dosage of Drosophila Piwi and Aubergine, which bind to novel germline-enriched
small non-coding RNAs called piRNAs, induces phenotypic variations that can be fixed in a population and
stably inherited in later generations. The study also showed that Piwi directly interacts with Hop and Hsp90 and
functions in the same pathway as Hsp90 in suppressing phenotypic variations. Further, we demonstrate for the
first time that Piwi becomes phosphorylated in an Hsp90 dependent manner, thus providing insights into how
Hsp90 may modulate Piwi's function in canalization. Crucially, this study also revealed two related yet distinct
Piwi/piRNA pathway-dependent mechanisms responsible for suppression of phenotypic variation: epigenetic
silencing of inherent genotype variations and suppression of transposon-mediated mutagenesis. Our work
revealed a framework of a pathway that suppresses phenotypic variation. Our working hypothesis is that
Hsp90 and Hop modulate Piwi function via its phosphorylation which then modulates Piwi function in
canalization. By further unraveling the inner workings of each step of this pathway, we aim to shed light on the
mechanisms that mediate this very important, yet poorly understood cellular phenomenon. The aims of the
proposal are to- 1) Discover new components that mediate and/or regulate Piwi function in canalization using
genetic screens, 2) Unravel the biochemical mechanism of Piwi mediated epigenetic regulation in canalization
and finally 3) Understand how Hsp90-Piwi/piRNA pathway counteracts environmental stress induced by
industrial pollutants like hexavalent chromium. Piwi proteins are present from protozoans to humans with
conserved functions in stem cell self-renewal and germ line maintenance. However their role in suppression of
phenotypic variation is a novel function that requires further characterization. Unraveling the mechanism by
which Piwi functions in canalization using Drosophila as a model system
will provide the necessary context for
understanding its roles in humans and learning how the dysfunction of this process might affect human
development and cause diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of piRNA pathway by the Nuclear Pore Complex
-
批准号:10629230
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2019
-
负责人:VAMSI GANGARAJU
-
依托单位:
Regulation of piRNA pathway by the Nuclear Pore Complex
-
批准号:10153819
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2019
-
负责人:VAMSI GANGARAJU
-
依托单位:
Regulation of piRNA pathway by the Nuclear Pore Complex
-
批准号:10404495
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2019
-
负责人:VAMSI GANGARAJU
-
依托单位:
Novel Role for Piwi/piRNA pathway in developmental robustness
-
批准号:8959624
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2013
-
负责人:VAMSI GANGARAJU
-
依托单位:
Novel Role for Piwi/piRNA pathway in developmental robustness
-
批准号:8521308
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2012
-
负责人:VAMSI GANGARAJU
-
依托单位:
Novel Role for Piwi/piRNA pathway in developmental robustness
-
批准号:8351811
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2012
-
负责人:VAMSI GANGARAJU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: